Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

CMS proposals aim to free physicians to spend more time with patients

CMS proposed several changes with wide-ranging goals, including aiming to reduce administrative burdens on doctors to spend more time with patients, the agency announced Thursday, July 12.

High valuations may curb healthcare M&A appetite of private equity groups

Healthcare M&A has been heating up for years, but sky-high valuations and rising competition may be causing some private equity buyers to walk away from the table.

Thumbnail

Massive deals among top factors driving healthcare M&A activity

Strong earnings, megadeals and promising demographics are helping drive healthcare M&A activity.

Thumbnail

Humana completes acquisitions of Kindred, Curo

Health insurance giant Humana—in a deal with private equity groups—closed its acquisitions of home health company Kindred Healthcare and hospice provider Curo Health Services.

Thumbnail

Americans have mixed feelings about value of medical care

Americans generally agree science has improved the quality of healthcare, but the vast majority consider it unaffordable, according to a recent Pew Research Center survey.

Thumbnail

CMS cuts funding for marketplace navigators for 2nd consecutive year

CMS announced it will award $10 million to the Navigator Program starting in the fall of 2018—representing a sharp decrease from $63 million in 2016.

Thumbnail

Pfizer backs down on drug price increases, announces split into three businesses

Following attacks by President Trump on Twitter, drugmaker Pfizer backed down on its previously announced plan to raise drug prices on a number of prescriptions. Pfizer also announced Wednesday it will reorganize into three businesses, effective in 2019.

Amazon’s OTC business offers pills at steep discount

Retail giant Amazon is selling over-the-counter (OTC) medicines at lower prices than its brick-and-mortar competitors.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”